Experts call for a pregnancy and lactation filter on ClinicalTrials.gov to close a basic access gap
Original reporting: STAT News
A group of experts writing in STAT News argues that ClinicalTrials.gov lacks a straightforward way for pregnant and lactating patients to identify trials they are eligible to join. They propose adding a dedicated checkbox as a low-cost structural fix to improve research access for a population that has historically been excluded from clinical trials.
Why it matters
The proposal is straightforward: add a checkbox to ClinicalTrials.gov that flags whether a trial accepts pregnant or lactating participants. Right now, identifying eligible trials requires reading through eligibility criteria manually, which is time-consuming for clinicians and practically impossible for patients navigating the site on their own. The authors frame this as a usability fix, and they are right that it is one.
But the checkbox also functions as a diagnostic tool. If the filter returns a thin list of results, that is useful information in itself. It would make visible, in a single search, how rarely pregnant and lactating people are written into trial eligibility criteria in the first place. The infrastructure improvement matters, and so does what the data behind it will reveal about how the research enterprise has treated this population.
The ReasonFirst take
A checkbox will not fix the deeper problem of protocols that exclude pregnant and lactating participants by default, so the real question is whether this surfaces eligible trials or exposes how few actually exist.
Who should care
What to watch
Whether NIH and the ClinicalTrials.gov team treat this as a metadata fix worth fast-tracking or let it stall in the longer queue of platform redesign priorities.
A question worth sitting with
If we built this filter today, how many trials would actually appear in the results for pregnant patients, and what would that number tell us about the state of inclusive trial design?
More signals
AI Is Lowering the Technical Barrier to Bioweapon Development, and Policy Is Not Keeping Up
STAT News · September 28, 2026
Indonesian Court Rules Against Patent Evergreening, Signaling a Shift in How Countries Can Challenge Pharma IP Tactics
STAT News · September 24, 2026
GLP-1 Cost Sharing and Rural AI Adoption Reveal Where Republican Health Policy Has Consensus
STAT News · September 14, 2026